Diastolic Pressure Could Play a Dirty Trick on Patients Treated for Hypertension

Having too low diastolic pressure could be linked to an increase in cardiovascular events (J-shape phenomenon). However, current guidelines suggest a target blood pressure under 130/80 mmHg with no lower limit for diastolic pressure.

Las nuevas guías Europeas de Hipertensión contrastan con las Americanas

This paper, recently published in JAMA, sought to evaluate the J-shape phenomenon of diastolic pressure in treated patients who reached a target systolic pressure under 130 mmHg—as guidelines recommend.

The cohort of patients was divided into the following intervals of diastolic pressure: less than 60 mmHg, between 60 and 70 mmHg, between 70 and 80 mmHg, and more than 80 mmHg.

The study’s primary endpoint was a composite of all-cause mortality, myocardial infarction, and stroke. The secondary endpoint included death due to cardiovascular causes, infarction, and non-fatal stroke.

The analysis included 7515 patients with a mean age of 65.6 years.

The lower risk for events was observed in patients with a diastolic pressure between 70 and 80 mmHg.


Read also: What to Do with Blood Pressure Levels Between 130/80 and 139/89 mmHg.


A mean diastolic pressure under 60 mmHg was linked to a significant increase in the primary endpoint risk (hazard ratio [HR]: 1.46; 95% confidence interval [CI]: 1.13-1.90; p = 0.004).

In relation to the composite, it was even more significant: death for cardiovascular causes (HR: 1.74; 95% CI: 1.26-2.41; p = 0.001), non-fatal stroke (HR: 1.73; 95% CI: 1.15-2.59; p = 0.008), and non-fatal stroke (HR 2.67; 95% CI: 1.26-5.63; p = 0.01).

Conclusion

This cohort study showed that a too low diastolic pressure (under 60 mmHg) was associated with an increase in cardiovascular events in treated patients who had reached a target systolic pressure of 130 mmHg or less.

The finding of an ideal systolic pressure between 70 and 80 mmH should be studied further.

Loading...

Original Title: Evaluation of Optimal Diastolic Blood Pressure Range Among Adults With Treated Systolic Blood Pressure Less Than 130 mm Hg.

Reference: Jingen Li et al. JAMA Network Open. 2021;4(2):e2037554. doi:10.1001/jamanetworkopen.2020.37554.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

Pretreatment with DAPT in Acute Coronary Syndrome: An Ongoing Debate?

In acute coronary syndrome (ACS) dual antiplatelet therapy (DAPT) has become a fundamental pillar after percutaneous coronary intervention (PCI), preventing stent thrombosis and acute...

SMART-CHOICE 3 | Efficacy and Safety of Clopidogrel vs Aspirin Monotherapy in High Risk Patients after Percutaneous Coronary Intervention

Courtesy of Dr. Juan Manuel Pérez. After post percutaneous coronary intervention (PCI) standard duration dual antiplatelet therapy (DAPT), the optimal long term monotherapy strategy is...

Patients at High Risk of Bleeding After Coronary Angioplasty: Are Risk Assessment Tools ARC-HBR and PRECISE-DAPT Useful?

Patients undergoing coronary stenting typically receive dual antiplatelet therapy (DAPT) for 6 to 12 months, consisting of a P2Y12 receptor inhibitor and aspirin. While DAPT...

ACC-2025 Congress Second Day Key Studies

BHF PROTECT-TAVI (Kharbanda RK, Kennedy J, Dodd M, et al.)The largest randomized  trial carried out across 33 UK centers between 2020 and 2024, assessing...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACURATE Neo2 Underexpansion: Prevalence and Clinical Implications

While transcatheter aortic valve replacement (TAVR) provides durable clinical benefits across a wide range of patients, technical challenges remain that may affect long-term outcomes....

Spontaneous Left Main Dissection: Clinical Characteristics, management and Outcomes

Courtesy of Dr. Juan Manuel Pérez. Spontaneous left main dissection in an uncommon, and potentially life-threatening, cause of acute MI. The aim of this study,...

Pretreatment with DAPT in Acute Coronary Syndrome: An Ongoing Debate?

In acute coronary syndrome (ACS) dual antiplatelet therapy (DAPT) has become a fundamental pillar after percutaneous coronary intervention (PCI), preventing stent thrombosis and acute...